期刊文献+

反义寡核苷酸对Lewis肺癌细胞合成VEGF的抑制作用 被引量:2

Effects of antisense oligodeoxynucleotides on vascular endothelial growth factor expression in Lewis lung carcinoma cells in vitro
暂未订购
导出
摘要 背景与目的血管内皮生长因子(VEGF)是一种特异地作用于血管内皮细胞的生长因子,它能促进血管内皮细胞增殖及新生血管的生成。本研究的目的是探讨脂质体介导的VEGF反义硫代寡核苷酸(ASODN)对培养的Lewis肺癌细胞合成VEGF的影响。方法将经脂质体包裹并经部分硫代修饰后的VEGFASODN、正义寡核苷酸(SODN)加入培养的Lewis肺癌细胞中,采用RT-PCR技术和免疫组织化学SP法检测肺癌细胞中VEGFmRNA和VEGF蛋白表达,同时测定各上清液刺激下血管内皮细胞生长的受抑情况。结果VEGFASODN能明显抑制Lewis肺癌细胞VEGFmRNA和VEGF蛋白表达,而且可以显著抑制内皮细胞的生长。结论VEGFASODN能抑制肺癌细胞表达VEGF,可以成为肺癌基因治疗的一种新的途径。 Background and objective Vascular endothelial growth factor (VEGF) can specially target the vascular endothelial cells so as to enhance their proliferation and angiogenesis. The aim of this study is to investigate the inhibition effects of VEGF antisense oligodeoxynucleotides (VEGF ASODN) on VEGF expression of Lewis lung carcinoma cells. Methods The phosphorothioate-modified and liposome-encapsulated VEGF ASODN, VEGF SODN were added into the medium of Lewis lung carcinoma cells respectively. VEGF mRNA and protein were detected by RT-PCR and immunohistochemistry. And the proliferation of vascular endothelial cells treated with supernatants was determined. Results VEGF ASODN could significantly inhibit the expression of VEGF mRNA and protein expression in Lewis lung carcinoma cells, as well as the proliferation of endothelial cells. Conclusion It is hopeful that VEGF ASODN may become a new antiangiogenesis therapy strategy in lung cancer.
出处 《中国肺癌杂志》 CAS 2007年第4期275-278,共4页 Chinese Journal of Lung Cancer
基金 黑龙江省科技攻关项目(GDDC190402)资助~~
关键词 反义寡核苷酸 血管内皮生长因子 LEWIS肺癌 Antisense oligodeoxynucleotide VEGF Lewis lung carcinoma
  • 相关文献

参考文献7

  • 1[1]Gunningham SP,Currie MJ,Han C,et al.Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas:regulation by the von Hippel-Lindau gene and hypoxia.Cancer Res,2001,61(7):3206-3211.
  • 2[2]Lang S,Hartner A,Sterzel RB,et al.Requirement of cyclin D1 in mesangial cell mitogenesis.J Am Soc Nephrol,2000,11 (8):1398-1408.
  • 3[3]Maeda K,Chung YS,Ogawa Y,et al.Prognostic value of vascular endothelial growth factor expression in gastric carcinoma.Cancer,1996,77(5):858-863.
  • 4[4]Koch AE,Harlow LA,Haines GK,et al.Vascular endothelial growth factor.A cytokine modulating endothelial function in rheumatoid arthritis.J Immunol,1994,152(8):4149-4156.
  • 5[5]Pruneri G,Bertolini F,Soligo D,et al.Angiogenesis in myelodysplastic syndromes.Br J Cancer,1999,81(8):1398-1401.
  • 6[6]Konishi T,Huang CL,Adachi M,et al.The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers.Int J Oncol,2000,16(3):501-511.
  • 7[7]Ho SP,Britton DH,Bao Y,et al.RNA mapping:selection of potent oligonucleotide sequences for antisense experiments.Methods Enzymol,2000,314:168-183.

同被引文献43

  • 1祝亮方,陈鑫基,林振兴,陈英玉,黄绿叶,胡建达.联合应用反义bcl-2和反义IL-6寡核苷酸对小细胞肺癌细胞株NCI-H446的作用[J].福建医科大学学报,2004,38(3):253-256. 被引量:1
  • 2朱志华,戎铁华,曾灿光,吴秋良,马芸,黄晓平,李宝江,张蓬原,赵进明,胡祎,张仕义,余辉,马国伟,张兰军,温浙盛,傅剑华,龙浩.Ⅰ~Ⅱ期非小细胞肺癌组织中VEGF的表达和微血管密度与预后的关系[J].癌症,2005,24(7):865-869. 被引量:10
  • 3惠燕,黄利鸣.survivin的研究进展[J].肿瘤研究与临床,2006,18(11):787-789. 被引量:4
  • 4雷炜,张彦,梁军,姚如勇,沈方臻.Bcl-2反义寡核苷酸增强小细胞肺癌细胞化疗敏感性研究[J].临床肿瘤学杂志,2007,12(1):20-22. 被引量:2
  • 5Yilmaz A, Emam D, Unsal E, et al. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer [J]. Arch Med Res, 2007,38 (7) : 764 --768.
  • 6Yoo J, Jung JH, Lee MA, et al. Immunohistoehemieal analysis of non-small cell lung cancer :correlation with clinical parameters and prognosis [J]. J Korean Med Sci, 2007,22 (2) : 318-- 325.
  • 7Ho QT,Kuo CJ. Vascular endothelial growth factor: Biology and therapectic applications [J]. Int J Biochem Cell Biol,2007,39(7-8):1349--1357.
  • 8Mcdonnell CO, Hill AD, Menamara DA, et al. Tumor micrometastases: The influence of angiohenesis[J]. Eur J Surg Oncol, 2000,26 (2) :105-115.
  • 9Seto T, Higashiyama M, Funai H, et al. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage Ⅰ non- smaLl-cell lung cancer [J]. Lung Cancer, 2006,53 (1) : 91--96.
  • 10Laack E, Scheffler A, Burkholder I,et al. Pretreatment vascular endothelial growth factor(VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) [J]. Lung Cancer, 2005,50(1) : 51-- 58.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部